FAS and cancer: Cancer cells develop capable de novo FAS machinery with an increase in the activity of key lipogenic enzymes such as adenosine triphosphate (ATP)-citrate lyase (ACLY), acetyl-CoA carboxylase (ACC), CoA carboxylase (ACACA), fatty acid synthase (FASN), and SCD (18).